SCHEMBL4964917

SCHEMBL4964917

N[C@H]1CCCN(P(N)(=O)Nc2ccc(O)cc2)C1=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 5/20 0.56
MAPT P10636 3/20 0.33
ALDH1A1 P00352 3/20 0.33
KDM4E B2RXH2 2/20 0.33
MEN1 O00255 2/20 0.33
THRB P10828 2/20 0.33
CASP1 P29466 2/20 0.33
RECQL P46063 2/20 0.33
KMT2A Q03164 2/20 0.33
HSD17B10 Q99714 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
USP2 O75604 1/20 0.33
POLB P06746 1/20 0.33
HSP90AA1 P07900 1/20 0.33
HSP90AB1 P08238 1/20 0.33
ALOX15 P16050 1/20 0.33
HTT P42858 1/20 0.33
BLM P54132 1/20 0.33
CYP3A4 P08684 1/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4966944 0.88 DPP4 (0.54) DPP4EPHX1GAARAB9A
SCHEMBL4966724 0.87 DPP4 (0.53) DPP4MAPTPOLBGAARAB9A
SCHEMBL4963263 0.87 DPP4 (0.53) DPP4MAPTALDH1A1MEN1KMT2A
SCHEMBL4963531 0.86 DPP4 (0.56) DPP4MAPTALDH1A1KDM4EKMT2A
SCHEMBL4968944 0.86 DPP4 (0.53) DPP4MAPTALDH1A1KDM4ETHRB
SCHEMBL4966659 0.84 DPP4 (0.50) DPP4MAPTALDH1A1KDM4EHTT
SCHEMBL4965133 0.84 DPP4 (0.50) DPP4EPHX1RAB9A
SCHEMBL4966920 0.83 DPP4 (0.50) DPP4MAPTALDH1A1MEN1KMT2A
SCHEMBL4964297 0.83 DPP4 (0.49) DPP4MAPTALDH1A1MEN1KMT2A
SCHEMBL4968301 0.80 DPP4 (0.46) DPP4KDM4EKMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1489088-B1 NOVEL ALPHA-AMINO-N-(DIAMINOPHOSPHINYL)LACTAM DERIVATIVE NIPPON KAYAKU KK (JP) 2008-08-13 EP disclosed
US-7348318-B2 α-Amino-N-(diaminophosphinyl)lactam derivatives NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2008-03-25 US disclosed
US-20050164989-A1 Novel $g(a)-amino-n-(diaminophosphinyl) lactam derivative NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2005-07-28 US disclosed
EP-1489088-A1 NOVEL ALPHA-AMINO-N-(DIAMINOPHOSPHINYL)LACTAM DERIVATIVE Nippon Kayaku Kabushiki Kaisha (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050164989-A1 Novel $g(a)-amino-n-(diaminophosphinyl) lactam derivative DNPEP, PEPD, ANPEP DPP4 8/4885MAPT 4819/4885ALDH1A1 1438/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.